Welcome to IRLAB’s Capital Markets Day 2022
IRLAB (Nasdaq Stockholm: IRLAB A) will host a capital markets day on Tuesday March 22, 2022, in Stockholm to present the company’s strategies, growth plan and key assets.
[mfn_before_post]
IRLAB (Nasdaq Stockholm: IRLAB A) will host a capital markets day on Tuesday March 22, 2022, in Stockholm to present the company’s strategies, growth plan and key assets.
The Capital Markets Day will be held at 12:15 CET on March 22, 2022, at Helio G30, Grev Turegatan 30, in Stockholm.
The program will provide an update on IRLAB’s long-term strategy and an external perspective on IRLAB’s projects and drug candidates. Mats Thoren, a seasoned investor and analyst within life science, will moderate. Representatives from IRLAB’s management team will be available for discussions.
A detailed agenda and a link for lunch registration follows.
12.15 – 13.00 Standing lunch
13.00 – 13.30 Introduction, strategy and growth
Introduction – Mats Thoren
Strategy and growth – CEO IRLAB, Dr Nicholas Waters
Parkinson’s and our key assets – CMO IRLAB, Dr Joakim Tedroff
13.30 – 14.00 Partnering with IRLAB
Introduction – CEO IRLAB, Dr Nicholas Waters
Ipsen & mesdopetam – Stephen Glyman, SVP Head of Neuroscience at Ipsen
14.00 – 15.00 IRLAB’s key assets
Introduction – CMO IRLAB, Joakim Tedroff
Mesdopetam – Professor of Neurology Karl Kieburtz
Pirepemat – Professor of Neurology Bastiaan Bloem
Market opportunities – CFO IRLAB, Viktor Siewertz
15.00 – 15.30 Pre-klinical projects
Pre-clinical projects – Dr Nicholas Waters & Dr Joakim Tedroff
Key takeaways – Mats Thoren
The Capital Markets Day will be sent live on IRLAB’s website, and a recording will be available after the event.
Participate on-site or online
It will be possible to participate in the Capital Markets Day on-site or online. Those who participate online will be able to submit their questions online.
To participate on site, please register at: https://financialhearings.com/event/43956/register/live_event
[mfn_after_post]